Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

Magnifying glass held over a CT scan image

Researchers from the University of Oxford will undertake the world’s first cancer prevention trial in adults with Li Fraumeni Syndrome (LFS). The “Metformin in Li Fraumeni” (MILI) trial is a randomised open-label Phase II trial jointly funded by the National Institute for Health Research and the Medical Research Council that will evaluate whether the existing type 2 diabetes drug metformin can prevent or delay the emergence of cancer in people with LFS.

LFS is a rare inherited disorder that currently impacts around 600 people in the UK but, with increasing use of self-testing and genetic sequencing in diagnostic practice, this number is expected to rise. LFS is caused by mutations in the TP53 tumour suppressor gene that encodes an important protein that prevents cancer. People with LFS have a 70-90% lifetime risk of developing a wide range of cancers, particularly cancers of the brain, breast, blood and soft tissue.

Read the full story on the Oxford Cancer website

Similar stories

Professor Sir Andrew Pollard Awarded the James Spence Medal in 2022

Professor Sir Andrew Pollard, BSc MA MBBS MRCP(UK) FRCPCH PhD DIC FHEA FIDSA FMedSci, is Professor of Paediatric Infection and Immunity at the University of Oxford, Honorary Consultant Paediatrician at Oxford Children’s Hospital and Vice Master of St Cross College, Oxford.

Department of Paediatrics celebrates 50-year anniversary

After being established in 1972, the Department of Paediatrics' contributions have spanned teaching, innovation, and research. The department also builds upon a longer lineage in Oxford that has impacted child health.

PhD Student of the Year 2022 Winner!

Congratulations to Nuffield Department of Women's & Reproductive Health DPhil student Josephine Agyeman-Duah on being named winner of PhD Student of the Year at the Postgrad Awards 2022.

Ethics at Westminster: A Workshop on Public Values and the Pandemic

At an event organised by the UK Pandemic Ethics Accelerator at the House of Commons on 18 May 2022, parliamentarians, policy makers and academics joined together to discuss how to bring ethical thinking and debate into public policy on pandemic recovery and preparedness, and how to involve the public.

Student Prizes for Biomedical Sciences and Medicine 2021-2022

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2021-2022 academic year.